Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL; SMART Study Group.

PLoS One. 2014 Jun 30;9(6):e101082. doi: 10.1371/journal.pone.0101082. eCollection 2014.

PMID:
24979386
[PubMed - in process]
Free PMC Article
2.

Metabolic Syndrome, Prediabetes, and Brain Abnormalities on MRI in Patients With Manifest Arterial Disease: The SMART-MR Study.

Tiehuis AM, van der Graaf Y, Mali WP, Vincken K, Muller M, Geerlings MI; for the SMART Study Group.

Diabetes Care. 2014 Jun 19. pii: DC_140154. [Epub ahead of print]

PMID:
24947788
[PubMed - as supplied by publisher]
3.

Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.

Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M; SMART Study Group.

Respirology. 2014 Aug;19(6):842-51. doi: 10.1111/resp.12319. Epub 2014 Jun 2.

PMID:
24889937
[PubMed - in process]
4.

The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.

van der Leeuw J, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL; on behalf of the SMART study group.

Heart. 2014 May 9. doi: 10.1136/heartjnl-2014-305490. [Epub ahead of print]

PMID:
24817441
[PubMed - as supplied by publisher]
5.

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.

Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, Mocroft A, Rockstroh J, Dore G, Lundgren JD; INSIGHT SMART Study Group.

J Clin Virol. 2014 Jul;60(3):295-300. doi: 10.1016/j.jcv.2014.03.017. Epub 2014 Apr 8.

PMID:
24793968
[PubMed - in process]
6.

Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

Miller CJ, Baker JV, Bormann AM, Erlandson KM, Huppler Hullsiek K, Justice AC, Neuhaus J, Paredes R, Petoumenos K, Wentworth D, Winston A, Wolfson J, Neaton JD; INSIGHT SMART Study Group; ESPRIT Study Group.

PLoS One. 2014 Apr 11;9(4):e95061. doi: 10.1371/journal.pone.0095061. eCollection 2014.

PMID:
24728071
[PubMed - in process]
Free PMC Article
7.

Parental history and the risk of subsequent vascular events in patients with clinically manifest vascular disease: the effects of sex of the parent and vascular disease location.

Weijmans M, van der Graaf Y, de Borst GJ, Nathoe HM, Algra A, Visseren FL; SMART study group.

Atherosclerosis. 2014 May;234(1):129-35. doi: 10.1016/j.atherosclerosis.2014.02.018. Epub 2014 Mar 3.

PMID:
24650753
[PubMed - in process]
8.

Factors associated with D-dimer levels in HIV-infected individuals.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee.

PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014.

PMID:
24626096
[PubMed - in process]
Free PMC Article
9.

Brain volumes and risk of cardiovascular events and mortality. The SMART-MR study.

van der Veen PH, Muller M, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2014 Jul;35(7):1624-31. doi: 10.1016/j.neurobiolaging.2014.02.003. Epub 2014 Feb 6.

PMID:
24582641
[PubMed - in process]
10.

Short-acting β-agonist use as a marker of current asthma control.

Patel M, Pilcher J, Munro C, Hosking A, Pritchard A, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group.

J Allergy Clin Immunol Pract. 2013 Jul-Aug;1(4):370-7. doi: 10.1016/j.jaip.2013.04.008. Epub 2013 Jun 5.

PMID:
24565542
[PubMed - indexed for MEDLINE]
11.

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease.

Kranendonk ME, de Kleijn DP, Kalkhoven E, Kanhai DA, Uiterwaal CS, van der Graaf Y, Pasterkamp G, Visseren FL; SMART Study Group.

Cardiovasc Diabetol. 2014 Feb 5;13:37. doi: 10.1186/1475-2840-13-37.

PMID:
24498934
[PubMed - in process]
Free PMC Article
12.

Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.

Kloppenborg RP, Geerlings MI, Visseren FL, Mali WP, Vermeulen M, van der Graaf Y, Nederkoorn PJ; SMART Study Group.

Neurology. 2014 Mar 4;82(9):777-83. doi: 10.1212/WNL.0000000000000168. Epub 2014 Jan 29.

PMID:
24477110
[PubMed - indexed for MEDLINE]
13.

Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.

Kanhai DA, de Kleijn DP, Kappelle LJ, Uiterwaal CS, van der Graaf Y, Pasterkamp G, Geerlings MI, Visseren FL; SMART Study Group.

BMJ Open. 2014 Jan 14;4(1):e003824. doi: 10.1136/bmjopen-2013-003824.

PMID:
24430876
[PubMed]
Free PMC Article
14.

Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study.

Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ; INSIGHT SMART Study Group.

J Electrocardiol. 2014 Mar-Apr;47(2):264-71. doi: 10.1016/j.jelectrocard.2013.12.001. Epub 2013 Dec 4.

PMID:
24406207
[PubMed - in process]
15.

Extracellular vesicle-derived CD14 is independently associated with the extent of cardiovascular disease burden in patients with manifest vascular disease.

Vrijenhoek JE, Pasterkamp G, Moll FL, Borst GJ, Bots ML, Catanzariti L, Weg SM, Kleijn DP, Visseren FL, Ruijter HM; on behalf of the SMART study group.

Eur J Prev Cardiol. 2014 Jan 7. [Epub ahead of print]

PMID:
24398371
[PubMed - as supplied by publisher]
16.

The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.

van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM; SMART Study Group.

Eur J Clin Invest. 2014 Mar;44(3):231-9. doi: 10.1111/eci.12222. Epub 2013 Dec 27.

PMID:
24372467
[PubMed - in process]
17.

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Cummins NW, Neuhaus J, Sainski AM, Strausbauch MA, Wettstein PJ, Lewin SR, Plana M, Rizza SA, Temesgen Z, Touloumi G, Freiberg M, Neaton J, Badley AD; INSIGHT SMART Study Group.

AIDS Res Hum Retroviruses. 2014 May;30(5):476-9. doi: 10.1089/AID.2013.0243. Epub 2014 Feb 14.

PMID:
24344953
[PubMed - in process]
18.

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.

Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R; SMART Study Group.

Lancet Respir Med. 2013 Mar;1(1):32-42. doi: 10.1016/S2213-2600(13)70007-9. Epub 2013 Mar 4.

PMID:
24321802
[PubMed - in process]
19.

LDL-c linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, de Borst GJ, Algra A, Spiering W, Visseren FL; The SMART Study Group.

Eur J Clin Invest. 2013 Nov 20. doi: 10.1111/eci.12206. [Epub ahead of print]

PMID:
24251769
[PubMed - as supplied by publisher]
20.

Risk of vascular events after nondisabling small and large vessel cerebral ischemia.

Achterberg S, Pruissen DM, Kappelle LJ, Algra A; SMART Study Group.

Cerebrovasc Dis. 2013;36(3):190-5. doi: 10.1159/000353675. Epub 2013 Oct 12.

PMID:
24135529
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk